EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer

PelvEx Collaborative

Colorectal Disease · 2024-05 · 26 (5) · 926-931

DOI: 10.1111/codi.16948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Disease, online erschienen am 02.04.2024. Verfasst von PelvEx Collaborative. Hauptthemen laut MEDLINE: Rectal Neoplasms, Pelvic Exenteration, Neoplasm Recurrence, Local, Margins of Excision. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The PelvEx Collaborative collates global data on outcomes following exenterative surgery for locally advanced and locally recurrent rectal cancer (LARC and LRRC, respectively). The aim of this study is to report contemporary data from within the collaborative and benchmark it against previous PelvEx publications.

Method

Anonymized data from 45 units that performed pelvic exenteration for LARC or LRRC between 2017 and 2021 were reviewed. The primary endpoints were surgical outcomes, including resection margin status, radicality of surgery, rates of reconstruction and associated morbidity and/or mortality.

Results

Of 2186 patients who underwent an exenteration for either LARC or LRRC, 1386 (63.4%) had LARC and 800 (36.6%) had LRRC. The proportion of males to females was 1232:954. Median age was 62 years (interquartile range 52–71 years) compared with a median age of 63 in both historical LARC and LRRC cohorts. Compared with the original reported PelvEx data (2004–2014), there has been an increase in negative margin (R0) rates from 79.8% to 84.8% and from 55.4% to 71.7% in the LARC and LRRC cohorts, respectively. Bone resection and flap reconstruction rates have increased accordingly in both cohorts (8.2%–19.6% and 22.6%–32% for LARC and 20.3%–41.9% and 17.4%–32.1% in LRRC, respectively). Despite this, major morbidity has not increased.

Conclusion

In the modern era, patients undergoing pelvic exenteration for advanced rectal cancer are undergoing more radical surgery and are more likely to achieve a negative resection margin (R0) with no increase in major morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsPelvic ExenterationNeoplasm Recurrence, LocalMargins of ExcisionHumansMiddle AgedFemaleMaleAgedTreatment OutcomeBenchmarkingPlastic Surgery ProceduresRetrospective Studies

Stichwörter der Autor:innen

international collaborationlocally advancedrectal cancersurgical outcomessurvival outcomes

Zitieren

APA

PelvEx Collaborative (2024). Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer. Colorectal Disease, 26(5), 926-931. https://doi.org/10.1111/codi.16948

Vancouver

PelvEx Collaborative. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer. Colorectal Disease. 2024;26(5):926-931. doi:10.1111/codi.16948

BibTeX
@article{PelvExCollaborative2024,
  author = {PelvEx Collaborative, PelvEx Collaborative},
  title = {Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer},
  journal = {Colorectal Disease},
  year = {2024},
  volume = {26},
  number = {5},
  pages = {926--931},
  doi = {10.1111/codi.16948}
}
Kostenlos starten →